Landscapes / Companies
Hangzhou Converd Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
Recombinant human IL-21-expressing oncolytic vaccinia virus, Phase 2 trial completes
Drugs
1
in active trials
Trials
2 active
2 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Advanced Pancreatic Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021